Another study found that liraglutide also reduced the activation of microglial cells in the brain's cortex and thalamus in diabetic rats by lowering the expression of NLRP3 protein, a marker of inflammation in brain microglia [104]
10.1016/j.kint.2021.06.013 83 PerroneR
What sets it apart from existing GLP-1 medications is that it is taken orally, rather than via injection
Clinical trials have shown that GLP-1 receptor agonists, particularly semaglutide and liraglutide, can reduce liver fat content and improve some markers of liver inflammation
Without approval, the patches should not be seen as a medical treatment or substitute for prescription GLP-1 medications
It is approved for individuals with a body mass index (BMI) of 30 or higher, or for those with a BMI of 27 or higher who also have at least one weight-related condition such as high blood pressure, high cholesterol, or sleep apnea